Abstract

The study of the role of serotonin in anxiety has led to the view that this neurotransmitter enhances anxiety, but inhibits panic. Validation of this hypothesis has been made using two experimental procedures that increase anxiety in human volunteers. One is classical conditioning of the skin electrical conductance response, which is assumed to represent anxiety. The other is simulated public speaking, which is believed to mobilize the same neural networks that are operative in panic and social anxiety disorders. In general, the results of these studies have fulfilled the predictions derived from the above hypothesis. The same procedures have been applied to panic disorder patients, and the obtained results have shown that these patients had a blunted anxiety response to public speaking. This speaking stress also did not activate the hypothalamic-pituitary-adrenal axis, which, in contrast, was activated by anticipatory anxiety. It may be concluded that anxiety and panic are qualitatively different emotional states, respectively related to the animal defense reactions to potential and proximal threat. In agreement, reported results of recent neuroimaging studies have shown that anxiety activates prefrontal cortical areas, whereas panic activates midbrain regions, particularly the periaqueductal gray matter. As a general conclusion, it may be said that anxiety, fear and panic do not belong to the same continuum of increasing intensity; instead, they are qualitatively different emotional states.

Highlights

  • The involvement of our research group with the defense-related emotions – anxiety, fear and panic – started with the study of the role played by the neurotransmitter serotonin or 5-hydroxytryptamine (5HT) in anxiety

  • Summarizing the reported evidence obtained with animal models of anxiety available in the late 1980s, it may be said that the reported results with conflict models, such as punished lever pressing maintained by water or food presentation in rats or key pecking maintained by food presentation in pigeons, indicated that 5-HT enhances anxiety

  • A controlled clinical assay conducted in patients with a diagnosis of generalized anxiety disorder (GAD) showed that the 5-HT2 receptor antagonist ritanserin is as effective as the benzodiapine anxiolytic lorazepam in reducing clinical symptoms after 2 weeks of drug treatment (Ceulemans, Hoppenbrouwers, Gelders, & Reyntjens, 1985)

Read more

Summary

Introduction

The involvement of our research group with the defense-related emotions – anxiety, fear and panic – started with the study of the role played by the neurotransmitter serotonin or 5-hydroxytryptamine (5HT) in anxiety. Two experimental procedures have been used: conditioning of the skin conductance response (CSCR) and simulated public speaking (SPS), which have been assumed to represent anxiety and panic, respectively.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call